A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria

Investigational Site Number : 0320002, Ciudad Autonoma Buenos Aires

Medical University of SC- Site Number : 8400004, Charleston

University of Florida-Genetics- Site Number : 8400010, Gainesville

UHCMC- Site Number : 8400014, Cleveland

Investigational Site Number : 3760001, Tel Litwinsky

University of Texas- Site Number : 8400002, Houston

Children's Hospital IMD Clinic- Site Number : 8400015, Aurora

University of California San Francisco- Site Number : 8400007, San Francisco

Hospital de Clinicas de Porto Alegre - HCPA- Site Number : 0760001, Porto Alegre

UPMC Children's Hospital of Pittsburgh-4401 Penn Ave- Site Number : 8400018, Pittsburgh

Investigational Site Number : 7920001, Ankara